The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cerebral ischemia or brain ischemia, is a condition that occurs when there isn't enough blood flow to the brain to meet metabolic demand. This leads to limited oxygen supply or cerebral hypoxia and leads to the death of brain tissue, cerebral infarction, orischemic stroke.
The global Brain Ischemia market was valued at US$ 535.3 million in 2023 and is anticipated to reach US$ 712.8 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Brain Ischemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Ischemia.
Report Scope
The Brain Ischemia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Ischemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Ischemia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bayer AG
- H. Lundbeck
- Bristol-Myers Squibb
- Boehringer Ingelheim
- ThromboGenics
- Vernalis
- Neurotec Pharma
- Johnson and Johnson
Segment by Type
- Anticoagulation Therapy
- Antiplatelet
- Other
Segment by Application
- Hospital
- Clinics
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Ischemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Ischemia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anticoagulation Therapy
1.2.3 Antiplatelet
1.2.4 Other
1.3 Market by Application
1.3.1 Global Brain Ischemia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Ischemia Market Perspective (2019-2030)
2.2 Brain Ischemia Growth Trends by Region
2.2.1 Global Brain Ischemia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Ischemia Historic Market Size by Region (2019-2024)
2.2.3 Brain Ischemia Forecasted Market Size by Region (2025-2030)
2.3 Brain Ischemia Market Dynamics
2.3.1 Brain Ischemia Industry Trends
2.3.2 Brain Ischemia Market Drivers
2.3.3 Brain Ischemia Market Challenges
2.3.4 Brain Ischemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Ischemia Players by Revenue
3.1.1 Global Top Brain Ischemia Players by Revenue (2019-2024)
3.1.2 Global Brain Ischemia Revenue Market Share by Players (2019-2024)
3.2 Global Brain Ischemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Ischemia Revenue
3.4 Global Brain Ischemia Market Concentration Ratio
3.4.1 Global Brain Ischemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Ischemia Revenue in 2023
3.5 Brain Ischemia Key Players Head office and Area Served
3.6 Key Players Brain Ischemia Product Solution and Service
3.7 Date of Enter into Brain Ischemia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Ischemia Breakdown Data by Type
4.1 Global Brain Ischemia Historic Market Size by Type (2019-2024)
4.2 Global Brain Ischemia Forecasted Market Size by Type (2025-2030)
5 Brain Ischemia Breakdown Data by Application
5.1 Global Brain Ischemia Historic Market Size by Application (2019-2024)
5.2 Global Brain Ischemia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Ischemia Market Size (2019-2030)
6.2 North America Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Ischemia Market Size by Country (2019-2024)
6.4 North America Brain Ischemia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Ischemia Market Size (2019-2030)
7.2 Europe Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Ischemia Market Size by Country (2019-2024)
7.4 Europe Brain Ischemia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Ischemia Market Size (2019-2030)
8.2 Asia-Pacific Brain Ischemia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Ischemia Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Ischemia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Ischemia Market Size (2019-2030)
9.2 Latin America Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Ischemia Market Size by Country (2019-2024)
9.4 Latin America Brain Ischemia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Ischemia Market Size (2019-2030)
10.2 Middle East & Africa Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Ischemia Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Ischemia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Brain Ischemia Introduction
11.1.4 Bayer AG Revenue in Brain Ischemia Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Detail
11.2.2 H. Lundbeck Business Overview
11.2.3 H. Lundbeck Brain Ischemia Introduction
11.2.4 H. Lundbeck Revenue in Brain Ischemia Business (2019-2024)
11.2.5 H. Lundbeck Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Brain Ischemia Introduction
11.3.4 Bristol-Myers Squibb Revenue in Brain Ischemia Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Brain Ischemia Introduction
11.4.4 Boehringer Ingelheim Revenue in Brain Ischemia Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 ThromboGenics
11.5.1 ThromboGenics Company Detail
11.5.2 ThromboGenics Business Overview
11.5.3 ThromboGenics Brain Ischemia Introduction
11.5.4 ThromboGenics Revenue in Brain Ischemia Business (2019-2024)
11.5.5 ThromboGenics Recent Development
11.6 Vernalis
11.6.1 Vernalis Company Detail
11.6.2 Vernalis Business Overview
11.6.3 Vernalis Brain Ischemia Introduction
11.6.4 Vernalis Revenue in Brain Ischemia Business (2019-2024)
11.6.5 Vernalis Recent Development
11.7 Neurotec Pharma
11.7.1 Neurotec Pharma Company Detail
11.7.2 Neurotec Pharma Business Overview
11.7.3 Neurotec Pharma Brain Ischemia Introduction
11.7.4 Neurotec Pharma Revenue in Brain Ischemia Business (2019-2024)
11.7.5 Neurotec Pharma Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Brain Ischemia Introduction
11.8.4 Johnson and Johnson Revenue in Brain Ischemia Business (2019-2024)
11.8.5 Johnson and Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
